Clinical trial
Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma
NCT05451134 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 30, 2022
- Completion date
- July 20, 2022
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.